JP2011503008A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011503008A5 JP2011503008A5 JP2010532334A JP2010532334A JP2011503008A5 JP 2011503008 A5 JP2011503008 A5 JP 2011503008A5 JP 2010532334 A JP2010532334 A JP 2010532334A JP 2010532334 A JP2010532334 A JP 2010532334A JP 2011503008 A5 JP2011503008 A5 JP 2011503008A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- antibody
- treatment
- symptoms
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000024891 symptom Diseases 0.000 claims 5
- 239000005557 antagonist Substances 0.000 claims 3
- 102000002227 Interferon Type I Human genes 0.000 claims 2
- 108010014726 Interferon Type I Proteins 0.000 claims 2
- 206010039710 Scleroderma Diseases 0.000 claims 2
- 230000008021 deposition Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000014509 gene expression Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- ZKRFOXLVOKTUTA-KQYNXXCUSA-N 9-(5-phosphoribofuranosyl)-6-mercaptopurine Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=S)=C2N=C1 ZKRFOXLVOKTUTA-KQYNXXCUSA-N 0.000 claims 1
- 201000004384 Alopecia Diseases 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 102100030323 Epigen Human genes 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 101000938352 Homo sapiens Epigen Proteins 0.000 claims 1
- 101000998969 Homo sapiens Inositol-3-phosphate synthase 1 Proteins 0.000 claims 1
- 101001006892 Homo sapiens Krueppel-like factor 10 Proteins 0.000 claims 1
- 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 claims 1
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 102100036881 Inositol-3-phosphate synthase 1 Human genes 0.000 claims 1
- 102000014150 Interferons Human genes 0.000 claims 1
- 108010050904 Interferons Proteins 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 102100027798 Krueppel-like factor 10 Human genes 0.000 claims 1
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims 1
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 claims 1
- 238000011529 RT qPCR Methods 0.000 claims 1
- 208000012322 Raynaud phenomenon Diseases 0.000 claims 1
- 206010040867 Skin hypertrophy Diseases 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 231100000360 alopecia Toxicity 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 229940079322 interferon Drugs 0.000 claims 1
- 201000001474 proteinuria Diseases 0.000 claims 1
- 206010040882 skin lesion Diseases 0.000 claims 1
- 231100000444 skin lesion Toxicity 0.000 claims 1
- 230000007838 tissue remodeling Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99617507P | 2007-11-05 | 2007-11-05 | |
| US60/996,175 | 2007-11-05 | ||
| US10045408P | 2008-09-26 | 2008-09-26 | |
| US61/100,454 | 2008-09-26 | ||
| PCT/US2008/082481 WO2009061818A1 (en) | 2007-11-05 | 2008-11-05 | Methods of treating scleroderma |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014075310A Division JP2014144966A (ja) | 2007-11-05 | 2014-04-01 | 強皮症の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011503008A JP2011503008A (ja) | 2011-01-27 |
| JP2011503008A5 true JP2011503008A5 (https=) | 2011-12-08 |
| JP5767475B2 JP5767475B2 (ja) | 2015-08-19 |
Family
ID=43087976
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010532334A Active JP5767475B2 (ja) | 2007-11-05 | 2008-11-05 | 強皮症の治療方法 |
| JP2014075310A Pending JP2014144966A (ja) | 2007-11-05 | 2014-04-01 | 強皮症の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014075310A Pending JP2014144966A (ja) | 2007-11-05 | 2014-04-01 | 強皮症の治療方法 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20110008365A1 (https=) |
| EP (1) | EP2219452B1 (https=) |
| JP (2) | JP5767475B2 (https=) |
| KR (1) | KR20100098620A (https=) |
| CN (1) | CN101909444B (https=) |
| AU (1) | AU2008324800B2 (https=) |
| BR (1) | BRPI0819195A2 (https=) |
| CA (1) | CA2703705A1 (https=) |
| CY (1) | CY1117251T1 (https=) |
| DK (1) | DK2219452T3 (https=) |
| ES (1) | ES2557352T3 (https=) |
| HR (1) | HRP20151403T1 (https=) |
| HU (1) | HUE025787T2 (https=) |
| IL (1) | IL205452A (https=) |
| MX (1) | MX2010004814A (https=) |
| NZ (1) | NZ585064A (https=) |
| PL (1) | PL2219452T3 (https=) |
| PT (1) | PT2219452E (https=) |
| RU (1) | RU2530561C2 (https=) |
| SI (1) | SI2219452T1 (https=) |
| WO (1) | WO2009061818A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20160855T1 (hr) | 2008-02-08 | 2016-09-23 | Medimmune, Llc | Anti-ifnar1 protutijela sa smanjenim afinitetom fc liganda |
| CN103732251A (zh) * | 2011-05-25 | 2014-04-16 | 米迪缪尼有限公司 | 用针对干扰素-α的抗体治疗全身性红斑狼疮、硬皮病以及肌炎的方法 |
| AU2013274389A1 (en) * | 2012-06-13 | 2015-01-22 | Astrazeneca Ab | Fixed dosage regimens for anti-type I interferon receptor (IFNAR) antibodies |
| US20180335431A1 (en) * | 2015-11-17 | 2018-11-22 | The Regents Of The University Of Colorado A Body Corporate | Novel multiplex assays to diagnose or evaluate diseases or disorders in mammals |
| HRP20231255T1 (hr) | 2021-04-23 | 2024-02-02 | Astrazeneca Ab | Režim doziranja anti-ifnar1 za potkožnu injekciju |
| CN118320101B (zh) * | 2024-06-14 | 2024-09-17 | 天津嘉氏堂科技有限公司 | iNOS抑制剂在制备治疗硬皮病胶原沉积药物中的应用 |
Family Cites Families (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3461808A (en) | 1967-07-03 | 1969-08-19 | Wood John Co | Diaphragm hand pumps |
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4444887A (en) | 1979-12-10 | 1984-04-24 | Sloan-Kettering Institute | Process for making human antibody producing B-lymphocytes |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| US4716111A (en) | 1982-08-11 | 1987-12-29 | Trustees Of Boston University | Process for producing human antibodies |
| EP0139676B1 (en) | 1983-02-04 | 1992-11-25 | Cytoclonal Pharmaceutics Inc. | Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins |
| GB8303165D0 (en) | 1983-02-04 | 1983-03-09 | Secher D S | Monoclonal antibody |
| DE3306060A1 (de) | 1983-02-22 | 1984-08-23 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| AU584417B2 (en) | 1985-04-01 | 1989-05-25 | Lonza Group Ag | Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
| EP0205404B1 (en) | 1985-06-11 | 1992-07-15 | Ciba-Geigy Ag | Hybrid interferons |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| EP0436597B1 (en) | 1988-09-02 | 1997-04-02 | Protein Engineering Corporation | Generation and selection of recombinant varied binding proteins |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE3923126A1 (de) | 1989-07-13 | 1991-01-17 | Stark Henric | Lautsprecherbox |
| US5413923A (en) | 1989-07-25 | 1995-05-09 | Cell Genesys, Inc. | Homologous recombination for universal donor cells and chimeric mammalian hosts |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| US5780225A (en) | 1990-01-12 | 1998-07-14 | Stratagene | Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules |
| WO1991010737A1 (en) | 1990-01-11 | 1991-07-25 | Molecular Affinities Corporation | Production of antibodies using gene libraries |
| EP1690934A3 (en) | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US4997008A (en) | 1990-04-26 | 1991-03-05 | Moen Incorporated | Faucet spout assembly |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ATE300615T1 (de) | 1990-08-29 | 2005-08-15 | Genpharm Int | Transgene mäuse fähig zur produktion heterologer antikörper |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5698426A (en) | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
| CA2405246A1 (en) | 1990-12-03 | 1992-06-11 | Genentech, Inc. | Enrichment method for variant proteins with alterred binding properties |
| DK0580737T3 (da) | 1991-04-10 | 2004-11-01 | Scripps Research Inst | Heterodimere receptorbiblioteker ved anvendelse af phagemider |
| EP0519596B1 (en) | 1991-05-17 | 2005-02-23 | Merck & Co. Inc. | A method for reducing the immunogenicity of antibody variable domains |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| CA2110799A1 (en) | 1991-06-14 | 1992-12-23 | Arnold H. Horwitz | Microbially-produced antibody fragments and their conjugates |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| ES2341666T3 (es) | 1991-12-02 | 2010-06-24 | Medimmune Limited | Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos. |
| EP1291360A1 (en) | 1991-12-13 | 2003-03-12 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| GB9203459D0 (en) | 1992-02-19 | 1992-04-08 | Scotgen Ltd | Antibodies with germ-line variable regions |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US5888511A (en) * | 1993-02-26 | 1999-03-30 | Advanced Biotherapy Concepts, Inc. | Treatment of autoimmune diseases, including AIDS |
| EP0733070A1 (en) | 1993-12-08 | 1996-09-25 | Genzyme Corporation | Process for generating specific antibodies |
| PT1231268E (pt) | 1994-01-31 | 2005-11-30 | Univ Boston | Bancos de anticorpos policlonais |
| US5516637A (en) | 1994-06-10 | 1996-05-14 | Dade International Inc. | Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage |
| CA2219361C (en) | 1995-04-27 | 2012-02-28 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| EP0823941A4 (en) | 1995-04-28 | 2001-09-19 | Abgenix Inc | HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES |
| US7285526B2 (en) * | 1995-07-14 | 2007-10-23 | Meiogen Biotechnology Corporation | Interferon antagonists useful for the treatment of interferon related diseases |
| GB9601081D0 (en) | 1995-10-06 | 1996-03-20 | Cambridge Antibody Tech | Specific binding members for human transforming growth factor beta;materials and methods |
| JP2978435B2 (ja) | 1996-01-24 | 1999-11-15 | チッソ株式会社 | アクリロキシプロピルシランの製造方法 |
| US6713609B1 (en) | 1996-07-16 | 2004-03-30 | Genentech, Inc. | Monoclonal antibodies to type I interferon receptor |
| US5916771A (en) | 1996-10-11 | 1999-06-29 | Abgenix, Inc. | Production of a multimeric protein by cell fusion method |
| EP1500329B1 (en) | 1996-12-03 | 2012-03-21 | Amgen Fremont Inc. | Human antibodies that specifically bind human TNF alpha |
| BRPI9809391B8 (pt) | 1997-04-14 | 2021-05-25 | Amgen Res Munich Gmbh | processo para a produção de um receptor de antígeno anti-humano, anticorpo humano e composição farmacêutica |
| US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| US6311415B1 (en) | 1998-09-14 | 2001-11-06 | Lind Shoe Company | Bowling shoe with replaceable tip |
| PT1355919E (pt) | 2000-12-12 | 2011-03-02 | Medimmune Llc | Moléculas com semivida longa, composições que as contêm e suas utilizações |
| US7087726B2 (en) | 2001-02-22 | 2006-08-08 | Genentech, Inc. | Anti-interferon-α antibodies |
| CA2454618C (en) * | 2001-07-24 | 2012-04-03 | Biogen Idec Ma, Inc. | Methods for treating or preventing sclerotic disorders using cd2-binding agents |
| CA2456753A1 (en) * | 2001-08-17 | 2003-02-27 | The Board Of Trustees Of The Leland Stanford Junior University | Mammalian relaxin receptors |
| BRPI0214168B8 (pt) * | 2001-11-14 | 2021-05-25 | Centocor Inc | anticorpos anti-il-6, moléculas de ácido nucleico codificando os mesmos, vetores compreendendo as referidas moléculas, composições e formulações compreendendo os referidos anticorpos, bem como métodos de produção dos mesmos |
| NZ547157A (en) | 2003-12-10 | 2009-07-31 | Medarex Inc | Interferon Alpha Antibodies and their uses |
| WO2005067963A1 (en) * | 2003-12-23 | 2005-07-28 | Intermune, Inc. | Use of polyethylene glycol-modified interferon-alpha in therapeutic dosing regimens |
| HUE035082T2 (en) | 2004-06-21 | 2018-05-02 | Squibb & Sons Llc | Interferon alpha receptor 1 antibodies and their use |
| EP1893646A2 (en) * | 2005-06-22 | 2008-03-05 | Genentech, Inc. | Methods and compositions for targeting ifnar2 |
| PT2327792E (pt) * | 2005-08-05 | 2013-11-21 | Genentech Inc | Métodos e composições para a detecção de distúrbios autoimunes |
| EP2077858A4 (en) | 2006-12-06 | 2011-07-20 | Medimmune Llc | INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS |
-
2008
- 2008-11-05 PT PT88476809T patent/PT2219452E/pt unknown
- 2008-11-05 RU RU2010122644/15A patent/RU2530561C2/ru active
- 2008-11-05 EP EP08847680.9A patent/EP2219452B1/en active Active
- 2008-11-05 US US12/741,262 patent/US20110008365A1/en not_active Abandoned
- 2008-11-05 CA CA2703705A patent/CA2703705A1/en not_active Abandoned
- 2008-11-05 NZ NZ585064A patent/NZ585064A/xx unknown
- 2008-11-05 JP JP2010532334A patent/JP5767475B2/ja active Active
- 2008-11-05 KR KR1020107012340A patent/KR20100098620A/ko not_active Ceased
- 2008-11-05 MX MX2010004814A patent/MX2010004814A/es active IP Right Grant
- 2008-11-05 WO PCT/US2008/082481 patent/WO2009061818A1/en not_active Ceased
- 2008-11-05 CN CN2008801242621A patent/CN101909444B/zh active Active
- 2008-11-05 ES ES08847680.9T patent/ES2557352T3/es active Active
- 2008-11-05 DK DK08847680.9T patent/DK2219452T3/en active
- 2008-11-05 PL PL08847680T patent/PL2219452T3/pl unknown
- 2008-11-05 BR BRPI0819195A patent/BRPI0819195A2/pt not_active Application Discontinuation
- 2008-11-05 SI SI200831557T patent/SI2219452T1/sl unknown
- 2008-11-05 HU HUE08847680A patent/HUE025787T2/en unknown
- 2008-11-05 HR HRP20151403TT patent/HRP20151403T1/hr unknown
- 2008-11-05 AU AU2008324800A patent/AU2008324800B2/en active Active
-
2010
- 2010-04-29 IL IL205452A patent/IL205452A/en active IP Right Grant
-
2014
- 2014-04-01 JP JP2014075310A patent/JP2014144966A/ja active Pending
-
2016
- 2016-01-11 CY CY20161100012T patent/CY1117251T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Branski et al. | Acute vocal fold wound healing in a rabbit model | |
| JP2011503008A5 (https=) | ||
| Di Battista et al. | One year in review 2021: systemic sclerosis | |
| RU2008145510A (ru) | Композиции и способы диагностики и лечения астмы или других аллергических или воспалительных заболеваний | |
| JP2020508303A5 (https=) | ||
| SG10201903512SA (en) | Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases | |
| SG10201407013QA (en) | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | |
| JP2004529079A5 (https=) | ||
| EA200971130A1 (ru) | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний | |
| JP2012532859A5 (https=) | ||
| JP2014501492A5 (https=) | ||
| Li et al. | Inhibition of Dectin-1 in mice ameliorates cardiac remodeling by suppressing NF-κB/NLRP3 signaling after myocardial infarction | |
| JP2017536380A5 (https=) | ||
| Liang et al. | Effects of interleukin 18 on injury and activation of human proximal tubular epithelial cells | |
| Lu et al. | Madecassoside ameliorates bleomycin‐induced pulmonary fibrosis in mice by downregulating collagen deposition | |
| JP2008528761A5 (https=) | ||
| JP2011510647A5 (https=) | ||
| ATE378051T1 (de) | Nicotinrezeptor-agonisten zur behandlung von entzündlichen lungenerkrankungen | |
| JP5749651B2 (ja) | 多形核細胞の動員および／または遊走を減少させる化合物および方法 | |
| WO2009099642A3 (en) | Proteomic analysis of active multiple sclerosis lesions | |
| EP4117659A1 (en) | Methods of treating respiratory disease with deupirfenidone | |
| Liu et al. | MiRNA, a new treatment strategy for pulmonary fibrosis | |
| RU2010122644A (ru) | Способы лечения склеродермии | |
| Jia et al. | Autophagy: A new treatment strategy for MSC-based therapy in acute kidney injury | |
| JP2018524274A5 (https=) |